Skip Navigation

Metastatic Breast Cancer Forum

  • Sixth Annual Metastatic Breast Cancer Forum 2017
    An Educational Program for Patients and Families

    Sponsored by the Susan F. Smith Center for Women’s Cancers and EMBRACE (Ending Metastatic Breast Cancer for Everyone), the Metastatic Breast Cancer Forum event is free of charge and open to patients with metastatic or advanced breast cancer, and their loved ones.

    Saturday, October 21, 2017
    8:15 a.m. – 4:00 p.m.
    Dana-Farber’s Yawkey Center for Cancer Care

    • Registration and light breakfast 8:15 to 9:00 a.m.
    • Box lunch and informal discussion with faculty
    • Post-conference reception

    Please RSVP: https://mbcforum2017.eventbrite.com

    Topics

    • What’s new in research and treatment for HER2 positive MBC
    • What’s new in research and treatment for triple negative MBC
    • What’s new in research and treatment for hormone positive MBC
    • What do we know about diet and exercise for MBC?
    • What’s new with genomics and MBC
    • Patient Panel – Living with MBC
    • Mock Tumor board with three cases presented

    Discussion Groups (led by social workers)

    • Living with MBC
    • Young women living with MBC

    Breakout Sessions

    • Palliative care: What is it and why it’s important
    • Managing fatigue and insomnia
    • Caregiver issues
    • Demystifying your genomics report

    Forum Director:  Nancy Lin, MD

    Speakers and Group Leaders

     

    Location
    Dana-Farber Cancer Institute
    Yawkey Center for Cancer Care
    Lavine Family Dining Pavilion (third floor)
    450 Brookline Ave.
    Boston, MA 02215

    Complimentary parking provided in Dana-Farber’s parking garage (under Dana-Farber’s Yawkey Center for Cancer Care). Enter the garage from Jimmy Fund Way.
    Directions and parking

    Previous Forums

    View highlights from the 2016 forum.  

    What is EMBRACE?

    Ending Metastatic Breast Cancer for Everyone(EMBRACE) is a research study at Dana-Farber. This study began in 2009, with the aim of learning more about the biology of advanced breast cancer, as well as the treatment experiences of patients who are living with it.

    Each patient’s progress is tracked by a study coordinator through medical records, and the information collected is used to help doctors understand more about the long-term journey of the metastatic breast cancer patients in this group. Investigators hope the study will bring them closer to finding a cure for metastatic breast cancer.

    The study is not sponsored by drug companies, and patients are not required to be on any drug trials.

    If you have questions about EMBRACE, please email Embrace@partners.org.